Key Takeaways
- Cerebras delivers Q2 financial results Wednesday after market close; Wall Street projects core revenue reaching $191 million, representing an 84% year-over-year increase
- Analysts anticipate an adjusted per-share loss of $0.17; profitability isn’t forecasted until 2026
- CBRS shares have declined over 25% since the beginning of the year, fluctuating within a $162-$244 range following its May debut
- Derivatives pricing indicates potential for an 11% upward move through week’s end, with August 14 contracts showing a 0.56x put-to-call ratio
- Wall Street maintains a “Strong Buy” consensus with an average target of $282, suggesting more than 20% potential gains
Cerebras Systems is scheduled to unveil its second-quarter financial performance Wednesday afternoon, setting the stage for what could be another dramatic trading session for CBRS stock on Thursday.
The company made its public debut in May with an IPO priced at $185 per share. Trading commenced at $350, surging to $386 before experiencing a sharp retreat that brought shares down to $161 by late June. The stock has since oscillated between $162 and $244.
On 42 of its 61 trading sessions, CBRS has experienced price swings exceeding 3% in either directionāan exceptionally high volatility rate for any publicly traded company.
As the earnings announcement approaches, shares have surrendered more than 25% of their value year-to-date.
The Street’s consensus calls for core revenue of $191 million. This figure would remain essentially unchanged from the previous quarter while marking an 84% surge compared to the same three-month period last year.
Cerebras employs a unique revenue calculation methodology. The company excludes pass-through revenue that generates zero margin while adding back warrant amortization expenses. In the previous quarter, this adjustment transformed reported sales of $193.4 million into a core revenue figure of $191.3 million.
Regarding profitability, analysts are forecasting an adjusted operating deficit of $62 million alongside an adjusted per-share loss of $0.17. An alternative consensus estimate places the expected loss at $0.21 per share, representing a modest improvement from Q1’s $0.22 loss.
The company isn’t anticipated to reach profitability until the following year.
Options Activity Points to Bullish Sentiment
Derivatives traders are displaying optimistic positioning ahead of the quarterly release. CBRS options contracts expiring August 14 show a put-to-call ratio of 0.56x, indicating stronger demand for calls relative to puts.
The upper strike prices on these contracts cluster just above $255. Should the bullish scenario materialize, this suggests shares could climb 11% by week’s end.
Technical indicators also show the stock recently clearing its primary moving averages, while the Relative Strength Index hovers in the mid-50sāa signal that accumulation has been underway.
Nevertheless, prudence remains warranted. CBRS commands a price-to-sales ratio exceeding 80x despite the absence of profitability. Additionally, company insiders haven’t executed a single purchase transaction over the past twelve months.
Understanding Cerebras’ Competitive Position
Cerebras manufactures the Wafer-Scale Engine (WSE), a chip spanning an entire 300mm silicon wafer. By integrating computing cores and memory onto a single silicon substrate, the design eliminates a critical performance limitation in AI server architecture.
This innovative approach proves particularly effective for inference operations, which are experiencing rapid growth as AI agent deployment accelerates.
The firm currently holds a $25 billion order backlog, predominantly stemming from a multi-year agreement with OpenAI to provide cloud-based Cerebras server access. OpenAI retains the right to expand this partnership further.
More recently, Cerebras has established partnerships with Amazon and AMD, where WSE processors complement their existing hardware for accelerated inference applications. The Amazon arrangement included equity warrants as part of the compensation structure.
Analyst consensus maintains a “Strong Buy” rating on CBRS stock. The $282 average price target represents potential upside exceeding 20% from present trading levels.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
